Emergent BioSolutions Inc. (EBS) stock
EBSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3074% below fair value
$5.61−0.20 (-3.44%)
Close on Nov 17, 2026Market cap $287.64MP/E –Yield –
Emergent BioSolutions market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Emergent BioSolutions's market cap was $309.85M on Nov 11, 2026, against $588.66M a year earlier. Over the last 5 years it ranged from $86.51M to $2.51B, with a median of $441.72M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $309.85M | -52.4% |
| 2025 | Dec 31, 2025 | $651.37M | +25.9% |
| 2024 | Dec 31, 2024 | $517.20M | +316.0% |
| 2023 | Dec 29, 2023 | $124.32M | -78.9% |
| 2022 | Dec 30, 2022 | $589.32M | -74.8% |
| 2021 | Dec 31, 2021 | $2.33B | -50.8% |
| 2020 | Dec 31, 2020 | $4.75B | +70.6% |
| 2019 | Dec 31, 2019 | $2.78B | -6.4% |
| 2018 | Dec 31, 2018 | $2.98B | +54.7% |
| 2017 | Dec 29, 2017 | $1.92B | +44.6% |
| 2016 | Dec 30, 2016 | $1.33B | -14.5% |
| 2015 | Dec 31, 2015 | $1.56B | +52.2% |
| 2014 | Dec 31, 2014 | $1.02B | +22.5% |
| 2013 | Dec 31, 2013 | $834.79M | +43.8% |
| 2012 | Dec 31, 2012 | $580.71M | -3.9% |
| 2011 | Dec 30, 2011 | $604.03M | -17.9% |
| 2010 | Dec 31, 2010 | $736.06M | – |
See a number that looks wrong?